Ignite Creation Date:
2025-12-24 @ 4:35 PM
Ignite Modification Date:
2026-02-27 @ 10:33 AM
Study NCT ID:
NCT05405166
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-11-14
First Post:
2022-05-31
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
SC Versus IV Isatuximab in Combination With Pomalidomide and Dexamethasone in RRMM
Sponsor:
Sanofi
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-06-23
Start Date Type:
ACTUAL
Primary Completion Date:
2024-11-06
Primary Completion Date Type:
ACTUAL
Completion Date:
2027-03-23
Completion Date Type:
ESTIMATED
First Submit Date:
2022-05-31
First Submit QC Date:
None
Study First Post Date:
2022-06-06
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2025-11-03
Results First Submit QC Date:
None
Results First Post Date:
2025-11-14
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-11-03
Last Update Post Date:
2025-11-14
Last Update Post Date Type:
ESTIMATED